Upregulation of PDCD4 expression in tumor cells increases the sensitivity for certain anti-cancer drugs, while downregulation of PDCD4 expression reduces the sensitivity for certain anti-cancer drugs [44]. Here, PDCD4 is linked to neoplasm.